Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$48.6

Avg closing price
Price range

15 Ray Dalio Nu Skin Enterprises Trades

The first Nu Skin Enterprises trade was made in Q2 2021. Since then Ray Dalio bought shares five more times and sold shares on nine occasions. The investor completely sold their stake between Q4 2023 and Q4 2024.

Avg closing price
Price range
Sold -32.4 Thousand shares Q4 2024
Avg closing price $6.88
Price range $6.07 - $7.83
Sold 52.8% shares (-36.2 Thousand shares) Q3 2024
Avg closing price $9.36
Price range $6.85 - $11.22
Sold 13.1% shares (-10.3 Thousand shares) Q2 2024
Avg closing price $12.67
Price range $10.54 - $13.89
Sold 13.2% shares (-12 Thousand shares) Q1 2024
Avg closing price $15.62
Price range $12.29 - $20.32
Sold 24.2% shares (-29 Thousand shares) Q4 2023
Avg closing price $18.45
Price range $16.33 - $20.76
Increased shares by 24.6% (+23.6 Thousand shares) Q3 2023
Avg closing price $25.99
Price range $21.02 - $33.54
Sold 3.6% shares (-3.6 Thousand shares) Q2 2023
Avg closing price $36.81
Price range $32.11 - $41.37
Sold 15.5% shares (-18.3 Thousand shares) Q1 2023
Avg closing price $41.57
Price range $38.17 - $45.38
Sold 14.8% shares (-20.5 Thousand shares) Q4 2022
Avg closing price $38.47
Price range $31.79 - $42.52
Sold 23.1% shares (-41.5 Thousand shares) Q3 2022
Avg closing price $41.64
Price range $33.37 - $47.20
Increased shares by 34.2% (+46 Thousand shares) Q2 2022
Avg closing price $45.90
Price range $42.33 - $51.27
Increased shares by 31.1% (+31.8 Thousand shares) Q1 2022
Avg closing price $49.56
Price range $43.07 - $55.79
Increased shares by 18.8% (+16.2 Thousand shares) Q4 2021
Avg closing price $44.45
Price range $39.79 - $52.18
Increased shares by 2.7% (+2.28 Thousand shares) Q3 2021
Avg closing price $50.60
Price range $40.47 - $56.96
New holding (+83.9 Thousand shares) Q2 2021
Avg closing price $56.92
Price range $51.65 - $62.44

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!